Prognostic significance and rationality of regular non-invasive imaging follow-up in Takayasu arteritis: A large multicenter cohort study


Yıldırım F., Tastekin F., Bakkal S., Kutu M. E., Ocak T., San S., ...Daha Fazla

Seminars in Arthritis and Rheumatism, cilt.74, 2025 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 74
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1016/j.semarthrit.2025.152813
  • Dergi Adı: Seminars in Arthritis and Rheumatism
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL
  • Anahtar Kelimeler: Imaging follow-up, Mortality, Prognosis, Takayasu Arteritis
  • Marmara Üniversitesi Adresli: Evet

Özet

Objectives: To investigate the prognostic significance of regular imaging follow-up in Takayasu arteritis (TAK) and assess its rationality. Methods: This was a retrospective multicenter cohort study. A total of 204 adult patients with TAK from 11 tertiary centers, and 580 imaging studies of these patients were included to encompass all concurrent clinical and laboratory findings. Results: The median follow-up time was 72 (36-96) months. Radiological activity and/or progression was observed in 116 (20 %) of the 580 imaging. A total of 418 (72 %) of the 580 imaging were performed while the physician's global assessment (PGA) was inactive. Radiological activity and/or progression was observed in only 18 (4 %) of the PGA inactive imaging. Younger age [OR 0.980; 95 % CI: 0.961-0.999, P = 0.041] and active PGA [OR 31.766; 95 % CI: 17.961-56.219, P < 0.001] were predictors of radiological activity and/or progression. There was no difference in terms of disease outcomes (MACE, VDI score, and mortality) between patients who underwent regular imaging follow-up regardless of clinical activity once a year or more and others. Conclusion: In the absence of clinical activity, the rate of radiological activity and/or progression is very low in patients with TAK during routine follow-up. It seems more reasonable to develop a personalised imaging follow-up plan that takes clinical activity findings into account rather than regular imaging follow-up.